Trials are highlighted when
- There is a pivotal Phase II or Phase III trial that is enrolling or results are expected to be presented for FDA review
- There is an ongoing trial with same or similar drugs.
Trials are highlighted when
Starting
January 1, 2025,
Clearity is joining
Ovarian Cancer
Research Alliance
(OCRA) and this website
will be redirected to
www.ocrahope.org
OCRA and Clearity are committed to serving the ovarian cancer community and providing the education, information, and support people need.